1. Home
  2. Investments
  3. TBAuctions

Online auction platform for used business equipment

TBAuctions at a glance & key developments in 2025

TBAuctions is Europe’s leading digital auction platform for B2B used goods, with over 1,100 employees across Europe. Guided by “Everything Has Value”, TBAuctions leverages technology, automation, and scale to streamline auctions. Its proprietary platform enables cross-border auctions, self-service, and efficient supply-demand matching, supporting sustainable trade by auctioning millions of products annually.

In 2025, TBAuctions advanced platform harmonization and cross-border functionality. Through product enhancements, operational discipline, and technology-driven efficiencies, the company reinforced its scalable platform and role in enabling circular trade across Europe.

Year acquired
2022
Revenue
EUR 229m
Location
The Netherlands
Employees
1154
Investment theme
Circularity
Gross profit
EUR 175m
SDG alignment

12, 13

What are the challenges TBAuctions addresses

  • 60%

    estimated increase in global raw material usage by 2060
  • 93%

    of materials used worldwide are neither reused nor recycled

  • Who is impacted?

    Buyers and sellers of used B2B goods, equipment manufacturers, and society at large are impacted by TBAuctions’ digital auction platform. Buyers and sellers benefit from efficient cross-border market access, while manufacturers are indirectly influenced through extended product lifecycles, higher residual values, and incentives to design more durable and circular equipment.

  • Contribution

    TBAuctions contributes to Summa’s theory of change by enabling reuse at scale through a digital marketplace that efficiently matches supply and demand for used equipment. The platform extends asset lifecycles, improves price transparency and market liquidity, reduces waste and resource depletion, and supports more circular and resource-efficient consumption.

  • Risks to impact

    Key risks to impact include limited market adoption or suboptimal reuse of auctioned goods, rapid technological advances reducing the relevance or efficiency of older equipment and rebound effects where lower prices for used goods stimulate increased consumption, potentially offsetting resource efficiency and circularity benefits.

KPI reporting

Number of items given a second life

Target 2027: 1.4 million

Change from '24-'25: -4%

2025
1.2m
2024
1.3m
2023
1.1m

Tracks the number of second-hand items sold through the platform, indicating extension of product lifecycles and continued use of existing assets.

Total number of unique active bidders

Target 2027: 1 million

Change from '24-'25: +13%

2025
790k
2024
702k
2023
607k

Total number of unique active bidders repre-sents individuals who have placed at least one bid within the year and is an indication of the vitality in the online second-hand market.

Total number of unique active sellers

Target 2027: 65k

Change from '24-'25: +14%

2025
54k
2024
47k
2023
38k

Total number of unique active sellers represents individuals or entities that have listed at least one item for sale within the year and is an indication of the activity in the online second-hand market.

  1. Home
  2. Investments
  3. Oda Group

Norway’s leading online grocery retail platform

Oda at a glance & key developments in 2025

Oda Group (Oda) is a leading Nordic online grocery platform, offering a wide range of food and household products at competitive prices with home delivery. Oda’s mission is to be the most efficient and sustainable online grocer, leveraging best-in-class operations and superior food waste reduction versus traditional retailers.

In 2025, Norway continued strong growth (14% YoY). In Sweden, Mathem restructuring was completed, with costs reduced and performance improving. Mathem has since shown positive growth and efficiency gains following transition to the Oda model. Oda Systems (Logistics-as-a-Service) launched, opening a significant new growth opportunity.

Revenue
EUR 508m
Location
Norway
Employees
1963
Investment theme
Sustainable Food
SDG alignment

12, 13

The challenges we face:

  • 1-2%

    global average spoilage share of operating revenues for conventional retail
  • 1.5kg

    CO2 emissions per order from store to home transportation in Norway

  • Who is impacted?

    Consumers in Norway and Sweden and society at large are impacted by Oda’s digital grocery platform. Consumers benefit from efficient access to groceries, while optimized logistics and inventory management reduce food waste and transport intensity, easing pressure on resources and emissions across the food value chain.

  • Contribution

    Oda contributes to Summa’s theory of change by enabling more efficient food distribution through a digital retail and logistics platform. By reducing spoilage and optimizing last-mile delivery, Oda lowers waste and emissions while supporting more resource-efficient grocery consumption.

  • Risks to impact

    Key risks to impact include limited control over supplier practices affecting shelf-life, as well as customer ordering behavior that increases delivery frequency or reduces route efficiency. These factors may reduce the effectiveness of Oda’s efforts to lower spoilage and emissions through operational efficiency.

KPI reporting

Average last mile delivery emissions per order (kg CO2e)

Target 2027: 0.6

Change from '24-'25: 0%

2025
0.8
2024
0.8
2023
1.1

Average last mile refers to the emissions associated with the final transportation leg of an order, from Oda’s distribution point to the customer’s home.

Spoilage share of operating revenue (%)

Target 2027: 0.2%

Change from '24-'25: -0.36ppt

2025
0.33%
2024
0.69%
2023
0.8%

Spoilage share is the amount of food spoiled, including food donated or sold through third parties, expressed as a share of Oda’s operating revenue.

Average climate footprint of food products (kgCO2 e/kg)

No target

Change from '24-'25: +6%

2025
1.7
2024
1.6
2023
1.7

Average climate footprint of food products is the emissions associated with the production and distribution of a food product sold by Oda.

  1. Home
  2. Investments
  3. Sengenics

Immunoprofiling for advanced biomarker discovery

Sengenics at a glance

Sengenics is a one-of-a-kind immune­proteomics company that leverages its patented KREX™ technology for production of full-length, correctly folded, and functional proteins. The technology is used to support pharma and academic research to advance precision medicine through an increased understanding of the autoimmune response in humans. Sengenics is currently focused on measurement of auto­antibodies for applications in autoimmune diseases, oncology, neurological conditions, and infectious disease.

Year acquired
2020
Employees
45
Investment theme
Changing Demographics
SDG alignments
3

What are the challenges Sengenics addresses

  • 80%

    of patients receive no benefit from treatment with the top 10 best-selling drugs in the world
  • 9.2%

    of OECD GDP is spent on healthcare

How does Sengencis help?

Reality today

We do not understand the biology of many leading diseases and lack appropriate biomarkers, preventing us from developing effective medication and delivering precision treatment.

Sengencis approach

Sengenics proteomics technology enables biological response research at unrivalled sensitivity and specificity, helping develop more targeted, effective, and efficient diagnostics and therapies.

Aspirational future

Deeper understanding of human biology and disease allows us to develop and deliver the most effective diagnostics and treatments for patients.

Who is impacted?

Researchers are impacted directly through more effective tools to understand human biology and more effective drug development. Patients are impacted indirectly through breakthroughs in treatments.

Contribution

Sengenics unique technology and collaborative partnerships with top biopharma companies contributes to the advancement of research on how to develop more targeted, effective and efficient diagnostics and therapies.

Risks

Sengenics impact depends in part on how its customers in biopharma choose to use its tools. Product quality is also fundamentally important, enabling reproducibility in research and precise, safe innovation in therapies.

KPI reporting

Accumulated no. of publications

Change from '22-'23: 28%

2023
51
2022
40
2021
31

Accumulated no. of publications measures the total publications produced using Sengenic’s technology and thereby contributing to precision medicine.

Data points generated

Change from '22-'23: 117%

2023
26m
2022
12m
2021
9m

Data points generated measures the total count of individual pieces of data on proteins or autoantibodies generated within a year.

Number of samples profiled

Change from '22-'23: -5%

2023
4,611
2022
4,833
2021
4,090

Number of samples profiled quantifies the total count of biological samples analyzed or characterized within a year.

  1. Home
  2. Investments
  3. LOGEX

Turning data into better healthcare

LOGEX at a glance & key developments in 2025

LOGEX offers advanced analytics that empower healthcare professionals to make data-driven decisions. As demand for care rises and human and financial resources decline, healthcare faces a complex balance between affordability, accessibility, and quality. Professionals must navigate constant change and difficult trade-offs. LOGEX helps customers identify and structure valuable data, transforming it into actionable intelligence that enables confident, evidence-based decisions and supports sustainable, high-quality care.

In 2025 & 2026, LOGEX has made changes to the management team to prepare for the next phase of growth – including a new CEO, CPO, and CRO. A strong organic growth is expected for 2026, and the company continues to maintain a healthy M&A pipeline.

Year acquired
2018
Revenue
EUR 58m
Location
Europe
Employees
419
Investment theme
Changing Demographics
SDG alignment

3, 9

What are the challenges LOGEX addresses

  • 9.2%

    of OECD GDP is spent on healthcare
  • 11m

    shortage of health workers projected globally by 2030

  • Who is impacted?

    Patients are impacted by the quality and affordability of care. Healthcare systems, including providers and payors, are impacted by the cost and efficiency of care delivery.

  • Contribution

    LOGEX’s growing suite of solutions contributes to accelerating the transition to more cost-effective, patient-centric, and integrated care – enabling players in the healthcare system to deliver optimal patient outcomes.

  • Risks to impact

    LOGEX works to maintain the highest data privacy and security standards, including meeting internationally recognized certifications, in order to mitigate risks posed by handling healthcare and patient data. The company’s impact also depends on the pace of transformation towards value-based care. LOGEX is working to help drive an inflection point for more rapid change.

KPI reporting

Healthcare institutions using LOGEX tools

No target

Change from '24-'25: 0%

2025
895
2024
895
2023
N/A

Tracks the number of healthcare institutions actively using LOGEX’s analytics tools, indicating adoption of data-driven solutions to optimize operations, improve efficiency, and enhance overall performance.

Impact stories captured

Target 2028: 80

Change from '24-'25: +25%

2025
50
2024
40
2023
30

Captures the number of documented cases where LOGEX analytics generate useful insights that support decision-makers and healthcare professionals in optimizing treatment.

  1. Home
  2. Investments
  3. Axion

Instruments for customers in biopharma and academia

Axion at a glance & key developments in 2025

Axion Biosystems (Axion) is a global life science tools business headquartered in the US that develops, produces, and markets BEA (Bioelectronic Assay) and live-cell imaging instruments for customers in biopharma and academia. Axion’s products enable scientists to understand cell function in real-time, enabling research and the development of new therapies across various pharmaceutical segments.

In 2025, Axion achieved significant bottom-line improvement alongside continued growth, driven by strong system sales and momentum in expanding its installed base. In addition, Axion acquired CytoTronics, adding a critical technology to the platform (note that the transaction closed in early 2026).

 

 

Year acquired
2021
Revenue
EUR 24m
Location
United States
Employees
114
Investment theme
Changing Demographics
SDG alignment

3, 9

What are the challenges Axion addresses

  • #1

    neurological conditions are the leading cause of ill health and disability worldwide and there are no treatments available to cure
  • 90%

    of drugs that pass through preclinical studies fail to meet the efficacy or safety margins required in subsequent trials

  • Who is impacted?

    Researchers in academia and biopharma and patients are impacted by Axion’s life science research tools. Scientists benefit from improved insights into cell function, while patients benefit indirectly through research and development activities informing future therapeutic innovation.

  • Contribution

    Axion contributes to Summa’s theory of change by enabling more effective preclinical research through bioelectronic assay and live-cell imaging instruments. Its tools support better biological understanding and data generation across drug discovery and development workflows.

  • Risks to impact

    Key risks to impact include limited adoption, inappropriate experimental use, or weak translation of research findings into clinical development, which may reduce the downstream relevance of insights generated using Axion’s technologies.

KPI reporting

Number of publications

Target 2027: 245

Change from '24-'25: +23%

2025
291
2024
237
2023
204

Tracks the number of scientific publications produced using Axion’s products, indicating adoption of its technologies in academic and biopharma research related to cell function and physiology.

Systems sold to Biopharma and CRO/CDMO companies

Change from '24-'25: +16%

2025
257
2024
222
2023
190

Tracks the number of systems sold to biopharma and CRO/CDMO companies, enabling organizations that develop new drugs and therapies to advance cutting-edge biotechnology research and production.

Number of experiments

Target 2027: 40k

Change from '24-'25: +1%

2025
18.2k
2024
18.1k
2023
15.8k

Tracks the total number of experiments conducted annually using Axion’s technology, measured by MEA and impedance plates purchased combined with Omni experiments run.

  1. Home
  2. Investments
  3. myneva

Software solutions provider for the social sector

myneva at a glance & key developments in 2025

The myneva Group is a leading European software provider for social services, with ~430 employees and 6,200+ customers serving ~1.8m clients. myneva’s software covers the full social sector, including elderly care, integration assistance, child and youth welfare, and social assistance. As the only software provider of its kind, myneva operates in eight European markets.

In 2025, myneva continued its growth journey with good organic growth as well as another strategic add-on with the acquisition of CareMates in July 2025, adding an AI-driven patient admission and documentation solution. The integration of both CareMates as well as of DM EDV (acquired end 2024) has been successfully completed and good progress has also been made on the product roadmap, where the company accelerated the rollout of its new products care, analytics and connect, driving adoption and supporting scalable platform growth.

Year acquired
2021
Revenue
EUR 57m
Location
Germany
Employees
430
Investment theme
Tech-Enabled Resilience
SDG alignment

3, 8, 10

What are the challenges myneva addresses

  • 25-36%

    of a caregiver’s time is dedicated to admin duties
  • 4m

    shortage of health & social care workers expected in Europe by 2030

  • Who is impacted?

    Care organizations, caregivers, clients and society at large are impacted by myneva’s social care software. Care providers benefit from streamlined administration, caregivers gain more time for care delivery, and clients benefit indirectly from more structured and coordinated care services.

  • Contribution

    myneva contributes to Summa’s theory of change by improving efficiency in social care through digital software that reduces administrative burden. Its solutions enable care organizations to allocate resources more effectively and support higher-quality care delivery amid workforce shortages.

  • Risks to impact

    Key risks to impact include inadequate implementation or onboarding within care organizations, as well as inconsistent user adoption across workflows. These factors may reduce the effectiveness of myneva’s software in lowering administrative burden and improving care delivery efficiency.

KPI reporting

Clients treated through myneva systems and solutions

Target 2030: 2,5m

Change from '24-'25: +18%

2025
1.8m
2024
1.6m
2023
1.5m

Measures the number of clients receiving care supported by caregivers using myneva’s systems, reflecting the reach of administrative efficiency gains enabled through digital care workflows.

Caregivers engaged through myneva systems and solutions

Target 2030: 839k

Change from '24-'25: +18%

2025
542k
2024
457k
2023
451k

Measures the number of caregivers using myneva’s systems, indicating adoption of digital tools that reduce administrative workload and support more efficient care delivery.

Admin time saved by caregivers per day through myneva systems and solutions (hours)

Target 2030: 418k

Change from '24-'25: +19 %

2025
433k
2024
364k
2023
224k

Captures the estimated administrative time saved for myneva customers (52min saved per 8h shift) through use of myneva’s systems, indicating potential time reallocated from administration to care activities.

  1. Home
  2. Investments
  3. Vyntra

The future of transaction intelligence

Vyntra at a glance & key developments in 2025

Born from the union of Intix and NetGuardians, Vyntra combines world-class expertise in financial crime prevention and transaction observability to redefine trust and transparency in financial services.

Vyntra helps financial institutions see, secure, and optimize every transaction in real time. From payment fraud and AML to transaction tracking, insider threat, and payment data visibility, Vyntra empowers financial institutions to detect threats faster, streamline compliance, and deliver resilient operations – without slowing down business. Beyond the integration and group rebranding, 2025 saw 11 new banks go live with Vyntra’s solutions.

Year acquired
2022
Revenue
EUR 21m
Location
Belgium
Employees
150
Investment theme
Tech-Enabled Resilience
SDG alignment

8, 10, 16

What are the challenges Vyntra addresses

  • 70%

    of adults have been exposed to a scam in the last 12 months
  • <1%

    of global illicit financial flows are intercepted by authorities

  • Who is impacted?

    Financial institutions, their customers and society at large are impacted by Vyntra’s transaction monitoring and financial crime solutions. Institutions gain improved oversight and control of transactions, while individuals and society benefit through reduced fraud exposure and increased trust in financial systems.

  • Contribution

    Vyntra contributes to Summa’s theory of change by enabling financial institutions to detect and prevent fraud, manage AML risks and ensure resilience of payment infrastructure in real time. Its platform strengthens the financial system’s integrity while supporting regulatory compliance and resilient banking operations.

  • Risks to impact

    Key risks to impact include technological performance or scalability limitations, as well as integration challenges within complex financial infrastructures. These factors may reduce the effectiveness of detecting financial crime globally and support regulatory compliance.

KPI reporting

Transactions monitored

Target 2029: 20bn

Change from '24-'25: +16%

2025
11.1bn
2024
9.6bn
2023
8.8bn

Tracks the total number of transactions monitored and analyzed through Vyntra’s platform, indicating the scale of transaction visibility and monitoring activity across customer systems.

Fraud prevented

No target

Change from '24-'25: +246%

2025
70.5k
2023
20.4k
2022
N/A

Tracks the number of fraudulent transactions identified and stopped using Vyntra’s solutions.

USD saved from fraud prevented

No target

Change from '24-'25: +109%

2025
735m
2024
352m
2023
N/A

Represents the estimated monetary value of financial losses avoided from confirmed fraud prevention events enabled by Vyntra’s solutions.

  1. Home
  2. Investments
  3. STIM

The aquaculture industry’s largest quality supplier of fish health products and services

STIM at a glance & key developments in 2025

STIM is the leading supplier of fish health products and services to the aquaculture industry. With over 33 years of experience, STIM offers a holistic approach that combines expertise in vaccines, pharmaceuticals, environmental monitoring, and regulatory advisory. Operating across Norway, Chile, Scotland, Ireland, Iceland, and North America, STIM supports farmers in improving fish health outcomes and long-term operational sustainability.

In recent years, STIM has continued to expand its distribution network and proprietary product portfolio while deepening its advisory offering, including through the acquisition of Pharmaq Analytic’s fish health and environmental services in the UK and Ireland.

Year acquired
2024
Revenue
EUR 170m
Location
Norway
Employees
104
Investment theme
Sustainable Food
SDG alignment

2, 14

What are the challenges Stim addresses

  • USD ~2bn

    in revenue loss for salmon farmers from mortality and downgrades
  • >15%

    fish mortality in salmon farming

  • Who is impacted?

    Fish farmers, coastal communities, marine ecosystems and society at large are impacted by STIM’s fish health products and services. Farmers benefit from improved fish health and operational stability, while healthier farming practices reduce biological stress and environmental pressure on surrounding marine ecosystems.

  • Contribution

    STIM contributes to Summa’s theory of change by improving fish health and welfare through preventative treatments, monitoring and advisory services. By supporting disease management and responsible farming practices, STIM helps farmers run more stable, productive and sustainable operations.

  • Risks to impact

    Key risks to impact include limited control over farming practices and treatment application beyond STIM’s direct oversight, as well as environmental effects in marine environments. These factors may reduce the effectiveness of STIM’s solutions in improving fish health and minimizing environmental impact.

KPI reporting

Distributed amount of preventative treatments and products

Target 2029: 356k

Change from '24-'25: -39%

2025
187k
2024
307k
2023
N/A

Tracks the amount of preventative treatments and products distributed by STIM, including pharmaceuticals and natural fish health products, supporting improved fish health management across the aquaculture industry.

Projects supporting marine environment and fish health

Target 2029: 3.6k

Change from '24-'25: +45%

2025
2.9k
2024
2k
2023
N/A

Tracks the number of advisory projects delivered by STIM across marine environment and fish health. Projects include veterinary visits and environmental monitoring and assessments to support sustainable aquaculture decisions.

Estimated number of fish supported through proprietary health products

Target 2029: 89.4m

Change from '24-'25: +11%

2025
77.9m
2024
70m
2023
N/A

Tracks the estimated number of fish supported through STIM’s proprietary health and biosecurity products, reflecting the scale of the company’s contribution to more sustainable aquaculture practices.

  1. Home
  2. Investments
  3. FAST LTA

Highly secure and compliant data storage and archiving technology solution

FAST LTA at a glance & key developments in 2025

FAST LTA is a leading German provider of high-security archiving, storage, and recovery solutions for business-critical and sensitive personal data. The company serves small to enterprise customers requiring strong data integrity, compliance, and protection against manipulation and ransomware, offering both long-term archiving and backup solutions.

In 2025, FAST LTA made good progress on its value creation journey, on or ahead of plan across all key parts of its 3 Phase Plan. In particular, the planned leadership transition has been completed with new CEO and CRO joining in Q2 2025, and a new CFO is starting in Q1 2026. Good progress has also been made on the product roadmap, for instance with the new product line Silent AI (launch in 2026).

Year acquired
2024
Revenue
EUR 27m
Location
Germany
Employees
117
Investment theme
Tech-Enabled Resilience
SDG alignment

9, 16

The challenges we face:

  • 96%

    of ransomware attacks specifically target backup locations and repositories
  • +65%

    rise in ransomware incidents targeting government entities worldwide in H1 2025

  • Who is impacted?

    Organizations in critical industries, especially healthcare and government institutions, and society at large are impacted by FAST LTA’s secure data archiving and recovery solutions. Institutions benefit from protected business-critical data, while individuals benefit indirectly through continuity of essential services and reduced data breach risks.

  • Contribution

    FAST LTA contributes to Summa’s theory of change by safeguarding sensitive and business-critical data through secure archiving, backup and recovery solutions. Its systems support data integrity, compliance and operational continuity in the face of cyberattacks or physical infrastructure failures.

  • Risks to impact

    Key risks to impact include human error in system configuration, access control, or encryption key management, as well as operational missteps during implementation. These factors may reduce the effectiveness of FAST LTA’s solutions in safeguarding data integrity and ensuring service continuity.

KPI reporting

Customers from critical industries

Target 2027: 1,962

Change from '24-'25: +5%

2025
1.882
2024
1.799
2023
1.767

The number of customers operating in critical industries, as defined by the German Federal Office for Information Security, whose services are essential to public safety and continuity of supply.

Data saved from archive product line

Target 2027: 100%

Change from '24-'25: 0%

2025
100%
2024
100%
2023
100%

The volume of data securely stored and protected through FAST LTA’s archive product line, indicating the scale of data safeguarded against loss, corruption, or unauthorized access.

Energy consumption per TB

Target 2027: 1.6

Change from '24-'25: +11%

2025
2
2024
1.8
2023
3

Measures the energy efficiency of FAST LTA’s storage solutions, showing watts consumed per terabyte of usable storage in a typical server room environment.

  1. Home
  2. Investments
  3. Tibber

Empowering 10 million households to embrace a fossil free future

Tibber at a glance & key developments in 2025

Tibber helps households power their homes smarter and more independently with real-time energy insights and smart controls, improving energy efficiency and reducing reliance on fossil fuels. By pooling this smart energy use across many homes, Tibber creates a Virtual Power Plant (VPP) — turning individual savings into collective grid support for a more stable, sustainable energy system.

In 2025, Tibber expanded its VPP, grid balancing services, and Grid Rewards across regions and smart devices, delivering measurable consumer savings. The company strengthened profitability in the Nordics, grew significantly in the Netherlands, and boosted operational efficiency.

Year acquired
2022
Revenue
EUR 68m
Location
Norway
Employees
294
Investment theme
Energy Transition
SDG alignemnt

7, 9, 13

What are the challenges Tibber addresses

  • +1.7TW

    of EU renewable electricity projects in grid connection queues
  • +8ppt

     increase in electrification rate to reach 2030 target of 32%

  • Who is impacted?

    Households, grid operators and society at large are impacted by Tibber’s energy platform. Households gain tools to manage and optimize electricity use, while aggregated customer flexibility supports grid balancing and integration of renewable energy, benefiting the wider energy system.

  • Contribution

    Tibber contributes to Summa’s theory of change by enabling flexible, demand-side energy use through digital tools and smart device integration. By aggregating household flexibility, Tibber supports more efficient electricity consumption and provides balancing resources for renewable-based power systems.

  • Risks to impact

    Key risks to impact include limited engagement with smart energy solutions, as well as regulatory, grid capacity, or technological constraints. Potential policy interventions, such as Norway’s price scheme or broader European consumer price gap mechanisms may also reduce flexibility incentives and market efficiency.

KPI reporting

Virtual Power Plant size (kwh)

No target

Change from '24-'25: +32%

2025
33m
2024
25m
2023
N/A

Represents the maximum theoretical capacity of Tibber’s Virtual Power Plant (VPP) end of December each year, powered by integrated customers devices. It reflects Tibber’s ability to optimize renewable energy usage, balance supply and demand, and support grid stability.

Number of smart charging sessions

No target

Change from '24-'25: +50%

2025
27m
2024
18m
2023
N/A

Tracks how often smart charging is initiated during low-price hours – helping customers lower energy costs, support a more stable and balanced grid and reduce reliance on fossil-based electricity.

Share of customers with solar installed

Target 2027: 20.8%

Change from '24-'25: +0.8 ppt

2025
14.5%
2024
13.7%
2023
8.8%

The share of customers who produce solar power, where Tibber helps optimize the use through smart solutions, such as solar smart charging and control in the Tibber app.